EQS-PVR: Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution
   EQS Voting Rights Announcement: Marinomed Biotech AG
   Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG
   with the objective of Europe-wide distribution

   24.10.2024 / 12:00 CET/CEST
   Dissemination of a Voting Rights Announcement transmitted by EQS News - a
   service of EQS Group AG.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018

    

   Wien,  23.10.2024

    

   Overview

   ☐  Notification made after deadline

   Caution: In case of violations of major holdings notification rules,
   please pay attention to Section 137 BörseG 2018 (Suspension of voting
   rights)

    

   1. Issuer: Marinomed Biotech AG

   2. Reason for the notification: Acquisition or disposal of voting rights

   3. Person subject to notification obligation
   Name: LLB Invest Kapitalanlagegesellschaft m.b.H.
   City: Wien
   Country: Österreich

   4. Name of shareholder(s): 

   5. Date on which the threshold was crossed or reached: 23.10.2024

   6. Total positions

                                    % of voting rights                 
                      % of voting        through                 Total number
                         rights      financial/other    Total of  of voting
                      attached to  instruments (7.B.1 + both in   rights of
                      shares (7.A)        7.B.2)        % (7.A +    issuer
                                                          7.B)
       Resulting                                                       
    situation on the    10,01 %           0,00 %        10,01 %   1 694 583
     date on which
     threshold was
   crossed / reached
      Position of                                                      
        previous         9,81 %                             
    notification (if
      applicable)

    

   Details

   7. Notified details of the resulting situation:

    

   A: Voting rights attached to shares
     ISIN Code          Number of voting rights          % of voting rights
                        Direct            Indirect        Direct    Indirect
                 (Sec 130 BörseG 2018) (Sec 133 BörseG   (Sec 130   (Sec 133
                                            2018)      BörseG 2018)  BörseG
                                                                      2018)
   ATMARIONOMED6                               169 666                10,01 %
    SUBTOTAL A                  169 666                       10,01 %

    

   B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1
   BörseG 2018
     Type of   Expiration Date   Exercise     Number of voting    % of voting
   instrument                     Period     rights that may be     rights
                                               acquired if the
                                                instrument is
                                                  exercised
                                                                             
                               SUBTOTAL B.1                                  

    

   B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2
   BörseG 2018
        Type of       Expiration   Exercise    Physical /    Number    % of
      instrument         Date       Period        Cash         of     voting
                                               Settlement    voting   rights
                                                             rights
                                                                             
                                              SUBTOTAL B.2                   

    

   8. Information in relation to the person subject to the notification
   obligation:

   ☒ Person subject to the notification obligation is not controlled by any
   natural person or legal entity and does not control any other
   undertaking(s) holding directly or indirectly an interest in the
   (underlying) issuer.

   ☐ Full chain of controlled undertakings through which the voting rights
   and/or the financial/other instruments are effectively held starting with
   the ultimate controlling natural person or legal entity:

    

   9. In case of proxy voting

   Date of general meeting: -

   Voting rights after general meeting: - is equivalent to - voting rights.

    

   10. Sonstige Kommentare:

   Die LLB Invest Kapitalanlagegesellschaft m.b.H. hält genannte Aktien als
   Verwaltungsgesellschaft (KAG) von Investmentfonds. Es gilt hinsichtlich
   der Zurechnung/Kontrolle die Ausnahme nach § 134 Abs 2 BörseG und § 8
   TransV 2018.

    

    Wien am  23.10.2024

    

   ══════════════════════════════════════════════════════════════════════════

   24.10.2024 CET/CEST

   ══════════════════════════════════════════════════════════════════════════

   Language: English
   Company:  Marinomed Biotech AG
             Hovengasse 25
             2100 Korneuburg
             Austria
   Internet: www.marinomed.com


    
   End of News EQS News Service


   2015487  24.10.2024 CET/CEST

slot demo

link slot demo

pengeluaran hk

keluaran hk

By adminn